Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...

Trials of a new asthma drug show that it could prove life changing for many people – who would only need two jabs a year. The ...

While yoga is essentially a physical act, it is more about the science of enlivening the body, mind, and breath in perfect ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.